Abstract:MicroRNA-21 (miR-21) inhibition is a promising biological strategy for breast cancer therapy. However its application is limited by the lack of efficient miRNA inhibitor delivery systems. As a cationic polymer transfection material for nucleic acids, the poly (l-lysine)-modified polyethylenimine (PEI-PLL) copolymer combines the high transfection efficiency of polyethylenimine (PEI) and the good biodegradability of polyllysine (PLL). In this work, PEI-PLL was successfully synthesized and confirmed to transfect plasmid and oligonucleotide more effectively than PEI in MCF-7 cells (human breast cancer cells). In this regard, two kinds of miR-21 inhibitors, miR-21 sponge plasmid DNA (Sponge) and anti-miR-21 oligonucleotide (AMO), were transported into MCF-7 cells by PEI-PLL respectively. The miR-21 expression and the cellular physiology were determined post transfection. Compared with the negative control, PEI-PLL/Sponge or PEI-PLL/AMO groups exhibited lower miR-21 expression and cell viability. The anti-tumor mechanism of PEI-PLL/miR-21 inhibitors was further studied by cell cycle and western blot analyses. The results indicated that the miR-21 inhibition could induce the cell cycle arrest in G1 phase, upregulate the expression of Programmed Cell Death Protein 4 (PDCD4) and thus active the caspase-3 apoptosis pathway. Interestingly, the PEI-PLL/Sponge and PEI-PLL/AMO also sensitized the MCF-7 cells to anti-tumor drugs, doxorubicin (DOX) and cisplatin (CDDP). These results demonstrated that PEI-PLL/Sponge and PEI-PLL/AMO complexes would be two novel and promising gene delivery systems for breast cancer gene therapy based on miR-21 inhibition.This work was a combination of the high transfection efficiency of polyethylenimine (PEI), the good biodegradability of polyllysine (PLL) and the breast cancer-killing effect of miR-21 inhibitors. The poly (l-lysine)-modified polyethylenimine (PEI-PLL) copolymer was employed as the vector of miR-21 sponge plasmid DNA (Sponge) or anti-miR-21 oligonucleotide (AMO). PEI-PLL showed more transfection efficiency and lower cytotoxicity in human breast cancer cells than PEI. Moreover, the breast cancer cells exhibited significantly lower miR-21 expression and cell viability post transfection with sponge or AMO. Interestingly, the PEI-PLL/miR-21 inhibitor complexes also sensitized the cancer cells to anti-cancer chemotherapy drugs, doxorubicin (DOX) and cisplatin (CDDP). This synergistic effect provides a good application prospect of co-delivery miR-21 inhibitors and chemical drugs in breast cancer therapy.

N-Isopropylacrylamide-modified Polyethylenimine-Mediated Mir-29A Delivery to Inhibit the Proliferation and Migration of Lung Cancer Cells

N-Isopropylacrylamide Modified Polyethylenimines as Effective siRNA Carriers for Cancer Therapy.

A Novel Thermophilic Histone with Promising Gene Transfection Efficiency

Lipoic Acid-Modified Oligoethyleneimine-Mediated Mir-34A Delivery to Achieve the Anti-Tumor Efficacy

N-Isopropylacrylamide-modified Polyethylenimine-Mediated P53 Gene Delivery to Prevent the Proliferation of Cancer Cells

miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy

Cationic Microrna-Delivering Nanocarriers for Efficient Treatment of Colon Carcinoma in Xenograft Model

A Novel Fluorinated Polyethyleneimine with Microrna-942-5p-sponges Polyplex Gene Delivery System for Non-Small-cell Lung Cancer Therapy.

Polymer‐initiating Caveolae‐mediated Endocytosis and GSH‐responsive MiR‐34a Gene Delivery System for Enhanced Orthotopic Triple Negative Breast Cancer Therapy

Polymeric vector-mediated delivery of an miR-21 inhibitor for prostate cancer treatment

Inhibitory Effect of Microrna-29C on Proliferation and Invasion of Human Prostate Cancer Cell Line LNCaP

Comparing the Variants of Iron Oxide Nanoparticle-Mediated Delivery of miRNA34a for Efficiency in Silencing of PD-L1 Genes in Cancer Cells

Biologically Responsive Carrier-Mediated Anti-Angiogenesis Shrna Delivery for Tumor Treatment

Programing Assembling/Releasing Multifunctional Mirna Nanomedicine to Treat Prostate Cancer.

In Vitro Studies of Polyethyleneimine Coated Mirna Microspheres As Anticancer Agents

PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells

Electroneutral composite polymersomes self-assembled by amphiphilic polyphosphazenes for effective miR-200c in vivo delivery to inhibit drug resistant lung cancer

Tumor-Targeting Anti-MicroRNA-155 Delivery Based on Biodegradable Poly(ester Amine) and Hyaluronic Acid Shielding for Lung Cancer Therapy

Preparation, characterisation, and in vitro cancer-suppression function of RNA nanoparticles carrying miR-301b-3p Inhibitor

Delivery of Mir‐3529‐3p Using MnO2‐SiO2‐APTES Nanoparticles Combined with Phototherapy Suppresses Lung Adenocarcinoma Progression by Targeting HIGD1A

Abstract 4427: Preparation and Mechanism of Polyethyleneimine Coated Mirna Let-7A Microspheres